NO20010114L - Profylaktiske behandlinger av neovaskularisering ved flekkdegenerering - Google Patents

Profylaktiske behandlinger av neovaskularisering ved flekkdegenerering

Info

Publication number
NO20010114L
NO20010114L NO20010114A NO20010114A NO20010114L NO 20010114 L NO20010114 L NO 20010114L NO 20010114 A NO20010114 A NO 20010114A NO 20010114 A NO20010114 A NO 20010114A NO 20010114 L NO20010114 L NO 20010114L
Authority
NO
Norway
Prior art keywords
neovascularization
prophylactic treatments
spot degeneration
degeneration
spot
Prior art date
Application number
NO20010114A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010114D0 (no
Inventor
Mark Cedric Gillies
Philip Leslie Penfold
Francis Alfred Billson
Original Assignee
Univ Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP4607A external-priority patent/AUPP460798A0/en
Priority claimed from AUPP5847A external-priority patent/AUPP584798A0/en
Application filed by Univ Sydney filed Critical Univ Sydney
Publication of NO20010114D0 publication Critical patent/NO20010114D0/no
Publication of NO20010114L publication Critical patent/NO20010114L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NO20010114A 1998-07-10 2001-01-08 Profylaktiske behandlinger av neovaskularisering ved flekkdegenerering NO20010114L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP4607A AUPP460798A0 (en) 1998-07-10 1998-07-10 Method of treatment
AUPP5847A AUPP584798A0 (en) 1998-09-11 1998-09-11 Method of treatment
PCT/AU1999/000565 WO2000002564A1 (en) 1998-07-10 1999-07-12 Prophylactic treatments of neovascularisation in macular degeneration

Publications (2)

Publication Number Publication Date
NO20010114D0 NO20010114D0 (no) 2001-01-08
NO20010114L true NO20010114L (no) 2001-02-22

Family

ID=25645823

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010114A NO20010114L (no) 1998-07-10 2001-01-08 Profylaktiske behandlinger av neovaskularisering ved flekkdegenerering

Country Status (9)

Country Link
US (1) US20050124594A1 (zh)
EP (1) EP1104302A4 (zh)
JP (1) JP2002520287A (zh)
KR (1) KR20010071827A (zh)
CN (1) CN1311684A (zh)
CA (1) CA2336703A1 (zh)
NO (1) NO20010114L (zh)
NZ (1) NZ509797A (zh)
WO (1) WO2000002564A1 (zh)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
ATE547080T1 (de) 2000-08-30 2012-03-15 Univ Johns Hopkins Vorrichtungen zur intraokularen arzneimittelabgabe
EP1621219A3 (en) * 2000-11-29 2006-03-22 Allergan, Inc. Intraocular implants for preventing transplant rejection in the eye
ES2250504T3 (es) * 2000-11-29 2006-04-16 Allergan Inc. Prevencion del rechazo de injerto en el ojo.
US20040091455A1 (en) * 2002-10-31 2004-05-13 Zeldis Jerome B. Methods of using and compositions comprising immunomodulatory compounds for treatment and management of macular degeneration
CA2504024A1 (en) * 2002-10-31 2004-05-21 Celgene Corporation Composition for the treatment of macular degeneration
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
CA2553381C (en) 2004-01-20 2011-03-22 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
WO2005072744A1 (ja) * 2004-02-02 2005-08-11 Yuichi Kaji 硝子体の可視化剤
US20050192264A1 (en) * 2004-02-04 2005-09-01 Penfold Philip L. Slow release steroid composition
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US20050244469A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
US20060089590A1 (en) 2004-10-27 2006-04-27 John Higuchi Methods and devices for sustained in-vivo release of an active agent
DK1836312T3 (da) * 2004-11-18 2012-03-12 Univ Yale Fremgangsmåder og sammensætninger til diagnosticeringer af aldersrelateret makulær degeneration
EP1919290B1 (en) 2005-07-12 2014-01-22 Ampio Pharmaceuticals, Inc. Methods and products for treatment of diseases
WO2007076454A1 (en) * 2005-12-23 2007-07-05 Alcon, Inc. Pharmaceutical formulation for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye
US8802128B2 (en) 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US20080097335A1 (en) 2006-08-04 2008-04-24 Allergan, Inc. Ocular implant delivery assemblies
NL1033357C2 (nl) 2007-02-08 2008-08-11 Arnaldo Goncalves Inrichting voor het met behulp van een injectie-naald intraoculair toedienen van een substantie, bijvoorbeeld een medicament, in een menselijk of dierlijk oog.
MX2010009974A (es) 2008-03-11 2010-09-30 Alcon Res Ltd Suspensiones de acetonida de triamcinolona de baja viscosidad, altamente floculadas para inyeccion intravitrea.
SG2014008163A (en) 2009-06-22 2014-04-28 Ampio Pharmaceuticals Inc Method for treatment of diseases
US9827401B2 (en) 2012-06-01 2017-11-28 Surmodics, Inc. Apparatus and methods for coating medical devices
CA2874824C (en) 2012-06-01 2021-10-26 Surmodics, Inc. Apparatus and methods for coating balloon catheters
CA2895340A1 (en) 2012-12-19 2014-06-26 Ampio Pharmaceuticals, Inc. Method for treatment of diseases
CN104193987A (zh) * 2013-01-21 2014-12-10 张雅珍 一种接枝药物的聚合物的制备和用途
EP3737381A4 (en) * 2018-01-10 2021-11-10 Eye Co Pty Ltd MEDICAL DEVICE AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF AN EYE DISEASE OR DISEASE
WO2020112816A1 (en) 2018-11-29 2020-06-04 Surmodics, Inc. Apparatus and methods for coating medical devices
US11819590B2 (en) 2019-05-13 2023-11-21 Surmodics, Inc. Apparatus and methods for coating medical devices

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1972197A (en) * 1932-04-20 1934-09-04 William J Mccann Hand protecting device
US4093709A (en) * 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4131648A (en) * 1975-01-28 1978-12-26 Alza Corporation Structured orthoester and orthocarbonate drug delivery devices
US4180646A (en) * 1975-01-28 1979-12-25 Alza Corporation Novel orthoester polymers and orthocarbonate polymers
US4079038A (en) * 1976-03-05 1978-03-14 Alza Corporation Poly(carbonates)
US4304767A (en) * 1980-05-15 1981-12-08 Sri International Polymers of di- (and higher functionality) ketene acetals and polyols
US5088498A (en) * 1988-10-17 1992-02-18 The Board Of Regents Of The University Of Washington Ultrasonic plethysmograph
US4946931A (en) * 1989-06-14 1990-08-07 Pharmaceutical Delivery Systems, Inc. Polymers containing carboxy-ortho ester and ortho ester linkages
US5310764A (en) * 1992-05-08 1994-05-10 Steven Baranowitz Treatment of age related macular degeneration with beta-carotene
AU7340694A (en) * 1993-07-27 1995-02-28 University Of Sydney, The Treatment of age-related macular degeneration
US5770589A (en) * 1993-07-27 1998-06-23 The University Of Sydney Treatment of macular degeneration
US6413536B1 (en) * 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US5968543A (en) * 1996-01-05 1999-10-19 Advanced Polymer Systems, Inc. Polymers with controlled physical state and bioerodibility
WO1997030704A2 (en) * 1996-02-26 1997-08-28 Advanced Research And Technology Institute Use of carbonic anhydrase inhibitors for treating macular edema
EP0946164A4 (en) * 1996-10-30 2000-08-23 Merck & Co Inc INTEGRIN ANTAGONISTS
DE19654750A1 (de) * 1996-12-30 1998-07-02 Helmut Dr Med Zander Verwendung von Wirkstoffen mit Östrogen-Wirkung zur Vorbeugung und Behandlung von Makuladegeneration
US6011023A (en) * 1997-08-27 2000-01-04 Alcon Laboratories, Inc. Angiostatic steroids
WO2001010421A1 (en) * 1999-08-06 2001-02-15 Board Of Regents, The University Of Texas System Drug releasing biodegradable fiber implant
CA2383499C (en) * 1999-10-21 2009-11-24 Alcon Universal Ltd. Drug delivery device
US6395294B1 (en) * 2000-01-13 2002-05-28 Gholam A. Peyman Method of visualization of the vitreous during vitrectomy
JP4787447B2 (ja) * 2000-01-20 2011-10-05 メルク・シャープ・エンド・ドーム・コーポレイション αｖインテグリン受容体拮抗薬
US6866864B2 (en) * 2000-03-20 2005-03-15 Ahmed Mousa Compositions and methods of use in the treatment of angiogenesis and vascular-related disorders
US6613355B2 (en) * 2000-05-11 2003-09-02 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US6696426B2 (en) * 2000-08-22 2004-02-24 Pharmacia Corporation Preservative free ophthalmic oxazolidinone antibiotic drug delivery systems
US6524606B1 (en) * 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups

Also Published As

Publication number Publication date
NZ509797A (en) 2003-11-28
EP1104302A4 (en) 2006-08-09
NO20010114D0 (no) 2001-01-08
JP2002520287A (ja) 2002-07-09
KR20010071827A (ko) 2001-07-31
WO2000002564A1 (en) 2000-01-20
CA2336703A1 (en) 2000-01-20
EP1104302A1 (en) 2001-06-06
CN1311684A (zh) 2001-09-05
US20050124594A1 (en) 2005-06-09

Similar Documents

Publication Publication Date Title
NO20010114L (no) Profylaktiske behandlinger av neovaskularisering ved flekkdegenerering
NO985652D0 (no) Anvendelse av naaladaseinhibitorer ved behandling av kreft
NO984163L (no) Forbedret syn ved fotodynamisk terapi av °yet
NO973178D0 (no) Indol-derivater anvendelige ved behandling av osteporose
NO990685L (no) FremgangsmÕte ved inkubering av u°nsket smak i orale sammensetninger
NO992069D0 (no) Konjugater som kan anvendes ved behandling av prostatakreft
DE69713907D1 (de) Wasserenthärtende Zusammensetzungen und Waschmittelzusammensetzungen
DE69727656D1 (de) Kationischer elektrobeschichtungsprozess und beschichtungszusammensetzung dafür
AU2002211379A1 (en) Compositions and methods for treatment of cystic fibrosis
DK0888297T3 (da) N-arylsulfiliminforbindelser og deres anvendelse som katalysatorer ved fremstillingen af N-arylarylsulfonamidforbindelser
GB2357712B (en) Pulveriser and method of pulverising
NO20023482D0 (no) Fremgangsmåte for behandling av stoffmisbruk
DE69916503D1 (de) Poliermittelzusammensetzung und anwendungsverfahren
NO20001412D0 (no) Sammensetninger og fremgangsmåter ved behandling av respiratoriske forstyrrelser
AU1359801A (en) Methods and compositions for treating reward deficiency syndrome
AU5679899A (en) Reduction of surfactant inactivation in pulmonary surfactant therapy
DE69939166D1 (de) Wasserenthärtungs- und waschmittelzusammensetzungen
FI962499A0 (fi) Herbisidien tehon parantaminen
NO20002804D0 (no) Konjugater som kan anvendes ved behandling av prostatakreft
NO20020031D0 (no) Dihydrobenzodiazepiner og deres anvendelse ved behandling av dyslipidemi
NO995518L (no) Arylsubstituerte piperaziner brukbare ved behandling av benign prostatisk hyperplasi
DK0924051T3 (da) Fremgangsmåde ved afgratning og affasning i ét trin
ID23174A (id) Bahan pelumas roda gigi terbuka
PL341318A1 (en) Derivatives of indole useful in treating oesteoporosis
ZA981781B (en) The use of levobupivacaine in treating migraine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application